SAFE vs Convertible Note
What is the difference between a SAFE and a convertible note — caps, interest, discounts?
Definition
A SAFE (Simple Agreement for Future Equity) is a contractual right to receive equity in a future priced round without creating debt, accruing interest, or having a maturity date — invented by Y Combinator in 2013. A convertible note is a short-term debt instrument that converts to equity at a future priced round, carrying interest (typically 2-8% annually) and a maturity date (12-24 months). Both instruments defer company valuation to a future round and use valuation caps and/or discounts to reward early investors. [src1]
Key Properties
- Legal nature: SAFE is equity-like (not debt); convertible note is debt that converts to equity
- Interest: SAFEs accrue no interest; convertible notes accrue 2-8% annually, added to principal at conversion
- Maturity date: SAFEs have none; convertible notes mature in 12-24 months
- Closing speed: SAFEs close in ~1.8 weeks; convertible notes take ~4.2 weeks
- Market share (2024): 88% of pre-priced rounds use SAFEs
- Valuation cap: Both can include a cap — max valuation at which investment converts
- Discount rate: Both typically include a 15-25% discount on next round price per share
Constraints
- SAFEs have limited legal recognition outside the US — convertible notes may be required [src1]
- Stacking multiple SAFEs without tracking creates dilution surprises at conversion [src2]
- Convertible note maturity creates legal risk — noteholders can demand repayment [src4]
- Neither instrument establishes a company valuation [src3]
- Interest rates on convertible notes rose 200-300 bps in 2024-2025 [src2]
Framework Selection Decision Tree
START — Founder needs pre-seed/seed funding
├── Is the company incorporated in the US (Delaware C-Corp)?
│ ├── YES → SAFE is the default instrument (88% market share)
│ └── NO → Check local jurisdiction; convertible note may be required
├── What's the investor preference?
│ ├── Angels / accelerators → SAFE (faster, simpler, no maturity risk)
│ ├── Institutional seed → SAFE with cap + discount (or priced round)
│ └── Bridge between rounds → Convertible note (debt priority)
├── Is there a near-term priced round expected?
│ ├── YES (< 6 months) → Either works; SAFE is faster
│ └── NO (> 12 months) → SAFE preferred (no maturity default risk)
└── Does the investor require interest accrual?
├── YES → Convertible note ← REQUIRED
└── NO → SAFE ← YOU ARE HERE (most cases)Application Checklist
Step 1: Choose the instrument
- Inputs needed: Jurisdiction, investor type, expected timeline to priced round
- Output: Decision: SAFE or convertible note
- Constraint: Verify SAFE enforceability in your jurisdiction [src1]
Step 2: Set the valuation cap
- Inputs needed: Traction, comparable valuations, amount raised
- Output: Cap amount (e.g., $8M cap for $1M raise)
- Constraint: Avoid uncapped instruments — they compound dilution unpredictably [src2]
Step 3: Set the discount rate
- Inputs needed: Investor return expectations, time to conversion, market norms
- Output: Discount percentage (typically 15-25%)
- Constraint: Model both cap and discount scenarios — investors get the more favorable [src3]
Step 4: Model conversion scenarios
- Inputs needed: SAFE/note amount, cap, discount, expected Series A valuation, option pool
- Output: Pro-forma cap table showing post-conversion ownership
- Constraint: Always model worst case where Series A valuation far exceeds cap [src5]
Anti-Patterns
Wrong: Raising multiple uncapped SAFEs assuming minimal dilution
Founders who raise 3-4 uncapped SAFEs discover at Series A that uncapped instruments convert at the Series A price, giving early investors far more equity than expected. [src2]
Correct: Always include a valuation cap and model cumulative dilution
Set a cap on every SAFE, then model what happens when all convert at the next round. [src3]
Wrong: Ignoring convertible note maturity dates
When a priced round stalls, noteholders can legally demand repayment, potentially forcing bankruptcy or fire-sale terms. [src4]
Correct: Negotiate extension provisions upfront
Include an automatic extension clause or use a SAFE to avoid maturity risk entirely. [src1]
Common Misconceptions
Misconception: SAFEs are "free money" because they are not debt and have no maturity date.
Reality: SAFEs always convert, diluting founders at the next priced round. The absence of a maturity date does not reduce their economic impact. [src3]
Misconception: A valuation cap means the company is valued at that amount today.
Reality: A cap is a ceiling on conversion price, not a valuation. [src1]
Misconception: Interest on convertible notes is paid in cash.
Reality: Interest accrues and is added to the principal at conversion. A $500K note at 6% for 18 months converts as ~$545K of equity. [src4]
Comparison with Similar Concepts
| Concept | Key Difference | When to Use |
|---|---|---|
| SAFE | Equity-like, no debt, no maturity, no interest | Default for US pre-seed/seed; fastest to close |
| Convertible Note | Debt instrument with interest + maturity date | Bridge rounds, international, when debt status needed |
| Priced Equity Round | Sets a fixed valuation and price per share | Series A and beyond; sufficient traction to price |
| Revenue-Based Financing | Repaid as % of revenue, no equity conversion | When founders want to avoid dilution entirely |
When This Matters
Fetch this when a founder asks about early-stage funding instruments, is comparing SAFEs to convertible notes, needs to understand valuation caps or discounts, or is deciding which instrument to use for a pre-seed or seed raise.